Zefeel-GM Cream
By Zefeel-GM
Rx
15gm Cream in a Tube

Composition
Clobetasol(0.05% w/w) + Miconazole(2% w/w) + Neomycin(0.5% w/w)

Manufacturer - Zephon Life Sciences
921- A, Industrial Area Phase 2, Chandigarh

Expires on or after
June, 2026

liver
No interaction or concerns have been found or established regarding the impact of Zefeel-GM Cream on the liver. It is always recommended to use caution when using any medication or cream, especially if you have existing liver issues. However, based on the available information, there are no known specific warnings or precautions related to liver safety when using Zefeel-GM Cream. It is advisable to follow the usage instructions provided and consult with your healthcare provider if you have any concerns or experience any unusual symptoms while using this cream.

kidney
No interaction between Zefeel-GM Cream and kidneys has been found. Consult with your doctor for proper guidance before using Zefeel-GM Cream.

alcohol
No interaction has been found or established between alcohol and Zefeel-GM Cream. It is always important to consider safety during pregnancy.

driving
Using Zefeel-GM Cream has not been shown to interact with driving abilities. It is important to always be cautious when driving, especially if you experience any side effects that may affect your focus or reaction time.

pregnancy
Zefeel-GM Cream may not be safe to use during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will assess the risks and benefits before recommending this cream. It is essential to consult your doctor regarding its use during pregnancy.

breastfeeding
Zefeel-GM Cream is considered safe for use during breastfeeding based on limited human data showing no significant risk to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | DERMA |
| Action Class | - |
₹64.8
₹72
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
